Learn More
  • Beata Holkova, Maciej Kmieciak, +23 authors Steven Grant
  • Clinical cancer research : an official journal of…
  • 2014
PURPOSE This phase I study was conducted to determine the dose-limiting toxicities (DLT) and maximum tolerated dose (MTD) for the combination of bortezomib and alvocidib in patients with B-cell(More)
  • 1